摘要
目的:观察"骨痹汤"对膝骨关节炎(OA)滑液中基质金属蛋白酶-13(Matrix Metalloproteinase-13,MMP-13)、白介素-1(Interleukin-1,IL-1)、肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)、组织型金属蛋白酶抑制剂-1(Tissue Inhibitor of Metalloproteinase-1,TIMP-1)水平的影响,探讨"骨痹汤"分子药理机制与临床疗效水平。方法:90例膝骨关节炎患者(119膝)随机分为骨痹汤治疗组、仙灵骨葆治疗组和对照组(口服硫酸氨基葡萄糖),于治疗前和治疗后8周抽取关节液标本,采用双抗体夹心酶联免疫吸附法测定MMP-13、IL-1、TNF-α、TIMP-1水平。结果:与治疗前比较,各组患者治疗8周后关节液中MMP-13、IL-1、TNF-α均明显降低(P<0.05);TIMP-1水平较治疗前明显升高(P<0.05);骨痹汤治疗组关节液中MMP-13、IL-1、TNF-α下降幅度较其余2组大(P<0.05),TIMP-1水平升高显著高于仙灵骨葆治疗组和对照组(P<0.05)。结论:骨痹汤可能通过降低关节炎液中MMP-13、IL-1、TNF-α水平,提高TIMP-1水平起到保护关节软骨的作用。骨痹汤治疗骨关节炎短期疗效较仙灵骨葆和硫酸氨基葡萄糖好。
Objective:To examine the expression of MMP - 13, IL - 1, TNF - α and TIMP - 1 in the synovial fluid in knee joints of osteoarthritis patients before and after being treated with Gubi decoction, and to explore the molecular pharmacological mechanisms and clinical efficacy. Methods:Ninety patients with osteoarthritis were recruited in the controlled trial, and randomly divided into Gubi de- coction group, Xianling Gubao Capsule group and control group (tablets of glucosamine sulfate). The expression of MMP- 13, IL- 1, TNF - α and TIMP - 1 in the synovial fluid was measured by enzyme - linked immunosorbent assay ( ELISA ) before and after 8 weeks of treatment. Results:The level of MMP - 13, IL - 1, TNF - α in the synovial fluid decreased significantly after being treated for 8 weeks in Gubi decoction group, Xianling Gubao Capsule group and glucosamine sulfate group (P 〈 0.05 ). On the contrary, the level of TIMP - 1 increased significantly after 8 weeks of treatment. Compared to Xianling Gubao Capsule group and glucosamine sulfate group, the level of MMP - 13, IL - 1, TNF - α decreased more sharply in Gubi decoction group(P 〈 0.05 ) , and also the increase of TIMP - 1 was significantly greater in Gubi decoction group( P 〈 0. 05 ). Conclusion: Gubi decoction may play a role in the protection of articular cartilage by decreasing MMP - 13, IL - 1, TNF - α and increasing TIMP - 1 levels in the synovial fluid. The short term effect of Gubi decoction in treatment of osteoarthritis was better than Xianling Gubao Capsule and glucosamine sulfate.
出处
《世界中医药》
CAS
2012年第6期488-490,共3页
World Chinese Medicine
基金
湖南省科技厅一般项目(编号:2011SK3180)